Immunic, Inc. (IMUX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 83.14M |
| Enterprise Value | 68.34M |
| P/E Ratio | -1.5 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.4 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.51 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.7 |
| Return On Equity | -1.58 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -97M |
| Net Income | -97.17M |
| Diluted EPS | -6.24 |
Balance Sheet
| Total Cash | 155.1M |
| Total Cash/Share | 3.65 |
| Total Debt | 567,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.05 |
| Book Value Per Share | 3 |
Price History
| 52-Week Change | -19.61 |
| 52-Week High | 17.43 |
| 52-Week Low | 5.06 |
| Moving Average 50 Days | 12.5 |
| Moving Average 200 Days | 11.41 |
Statistics
| Average Volume | 289,043 |
| Shares Outstanding | 13.62M |
| % Held by Institutions | 282.06 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 27, 2026 |
AD
